According to a new study, people who eat faster or take larger bites are more likely to eat more at a meal. The research, which is being presented at NUTRITION 2021 LIVE ONLINE, provides new insight into the factors that might contribute to overeating.
A new study of more than 350,000 women found that women with diets incorporating more foods that increase inflammation in the body had a 12% increase in their risk of breast cancer compared to women who consume more anti-inflammatory diets.
There has been a long-standing debate as to whether a low-fat or a plant-centered diet is better at lowering the risk of cardiovascular disease. A new study that followed more than 4,700 people over 30 years, found that a plant-centered diet was associated with a lower long-term risk for cardiovascular disease. However, both diets were linked with lower LDL, or bad cholesterol, levels.
Only 5% of men and 9% of women are getting the recommended daily amount of dietary fiber, according to a study being presented at NUTRITION 2021 LIVE ONLINE. Insufficient fiber intake is associated with a higher risk of heart disease and diabetes, two of the most common diseases in the U.S.
According to a new study, adults overall ate more refined grains and solid fats and children increased their intake of added sugar during the recession. The impacts of the downturn were especially pronounced in food-insecure households, where individuals significantly reduced their intake of protein and dark green vegetables while increasing total sugars.
Studies being presented at NUTRITION 2021 LIVE ONLINE bring new insights into how people ate, shopped and felt about food as the COVID-19 pandemic unfolded. Studying these trends can shed light on potential lingering health impacts of the pandemic and inform responses to future emergencies.
What we eat during childhood can affect the health of individuals—and populations—for years to come. As rates of childhood obesity continue to rise, five studies being presented at NUTRITION 2021 LIVE ONLINE bring new insights into the diets of children and teens around the world.
Superfoods like turmeric and honey have long been recognized for their ability to promote health and wellness. New studies being presented at NUTRITION 2021 LIVE ONLINE take a closer look at the science behind the health benefits of superfoods.
Healthy habits are particularly important during pregnancy. Four new studies being presented at NUTRITION 2021 LIVE ONLINE look at how supplements, eating habits and physical activity can affect various aspects of health during pregnancy.
Even moderate smartphone use may influence teens’ diet and weight, according to a new study of more than 53,000 Korean adolescents. Teens who used a smartphone for more than 2 hours per day were significantly more likely to eat more junk food and fewer fruits and vegetables than those spending less time on their phone. Teens spending more than 3 hours per day on a smartphone were significantly more likely to be overweight or obese.
A pain-management protocol designed by Emese Zsiros, MD, PhD, FACOG, to be reported at the American Society of Clinical Oncology 2021 annual meeting, resulted in a 45% decrease in opioids prescribed to patients undergoing surgery, without significant effect on recovery or satisfaction.
The Roswell Park Comprehensive Cancer Center/Kaiser Permanente Northern California team behind a new study to be highlighted at the ASCO 2021 virtual annual meeting has found that sufficient vitamin D levels at the time of diagnosis are associated with improved outcomes among people with breast cancer.
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial led by Washington University School of Medicine in St. Louis. The drug is designed to shut down the effects of the mutation, which is found in about 13% of patients with lung adenocarcinoma, a common type of non-small-cell lung cancer.
Results from the Phase II cohort of the CodeBreaK 100 study showed that treatment with the KRAS G12C inhibitor sotorasib achieved 12.5 months median overall survival in previously treated patients with KRAS G12C-mutated non-small cell lung cancer, according to researchers from The University of Texas MD Anderson Cancer Center.
ROCHESTER, Minn. — A study by researchers at Mayo Clinic Cancer Center has found that cancer patients diagnosed with COVID-19 who received care at home via remote patient monitoring were significantly less likely to require hospitalization for their illness, compared to cancer patients with COVID-19 who did not participate in the program. Results of the study were presented Friday, June 4, at the American Society of Clinical Oncology Annual Meeting and published in the Journal of Clinical Oncology.
At the American Society of Clinical Oncology 2021 virtual Annual Meeting, Roswell Park teams will share data and insights on topics ranging from reducing use of opioids to an analysis of trends in response to cancer treatment among patients of different races.
New data from researchers at Memorial Sloan Kettering Cancer Center (MSK) featured in the 2021 ASCO Annual Meeting press program highlights a promising new treatment option for individuals previously treated for metastatic castration-resistant prostate cancer (mCRPC).
Treatment with an immunotherapy drug following kidney cancer surgery, prolonged disease-free survival rates in patients at high risk for recurrence, according to an interim report of a phase 3 clinical trial of adjuvant immunotherapy in this patient population.
ACSM's comprehensive sports medicine and exercise science conference takes place virtually from June 1 to 5 with programming covering the science, practice, public health and policy aspects of sports medicine, exercise science and physical activity.
A treatment regimen for patients with advanced melanoma that combines the immunotherapy agents relatlimab (anti-LAG-3) and nivolumab (anti-PD-1) delayed time to cancer progression significantly more than nivolumab alone, according to results of a study to be presented June 6 at the 2021 American Society of Clinical Oncology (ASCO) annual meeting.
Moffitt Cancer Center, a national leader in cancer care and research and the only National Cancer Institute-designated Comprehensive Cancer Center based in Florida, is presenting new data from dozens of clinical research studies at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting, the world’s largest clinical cancer research meeting. Moffitt investigators will lead 25 abstract presentations, five education sessions, two cancer-based panels and two clinical science symposia. The virtual meeting is June 4-8.
Press materials are now available for NUTRITION 2021 LIVE ONLINE, a dynamic virtual event showcasing new research findings and timely discussions on food and nutrition. The online meeting will be held June 7–10, 2021.
An odor-based test that sniffs out vapors emanating from blood samples was able to distinguish between benign and pancreatic and ovarian cancer cells with up to 95 percent accuracy.
In the longest follow-up results from a clinical trial of combination immunotherapy for metastatic melanoma, investigators report that nearly half the patients who received the drugs nivolumab and ipilimumab were alive a median of six and a half years after treatment.
Dr. Kenneth Wells, UCLA Fielding School of Public Health professor of health policy and management, will collaborate with colleagues at UCLA and the Department of Veteran’s Affairs to lead this week’s “Veteran Resilience and Recovery” conference at UCLA, created to focus on the veteran community, including addressing homelessness and behavioral health.
Several Phase II clinical trials conducted by researchers from The University of Texas MD Anderson Cancer Center show promising results for patients with melanoma, breast cancer, HER2-positive tumors and ovarian cancer. The results of these studies, which will be presented at the virtual 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, highlight new advances in drug therapy research to improve patient outcomes.
The virtual Annual Meeting of the American Society of Clinical Oncology (ASCO), the largest medical meeting on the latest cancer research findings, will include several presentations by investigators from The Tisch Cancer Institute at Mount Sinai. Mount Sinai physician scientists will present leading research studies, including oral presentations on bladder cancer and disparities in cancer.
A combination of ponatinib and blinatumomab was found to be safe and highly effective in patients with newly diagnosed or relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL), according to researchers at The University of Texas MD Anderson Cancer Center. The study may support a regimen to produce complete remission with front-line therapy, without the increased risks associated with systemic chemotherapy or a stem cell transplant.
Cancer drugs capable of weakening the body’s immune defenses are no more likely to increase the risk of Covid-19 infection or death than breast cancer therapies that do not undermine the immune system, a new study shows.
A metabolic inhibitor drug, IACS-6274, developed by MD Anderson's Therapeutics Discovery division, is well-tolerated and showed early signs of anti-tumor activity in a Phase I trial being presented at the 2021 ASCO Annual Meeting.
Rutgers Cancer Institute of New Jersey, a leader in cutting-edge clinical trials and health outcomes analyses and a designated Comprehensive Cancer Center by the National Cancer Institute, together with RWJBarnabas Health, today announced that data from its cancer clinical research program will be presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting, to be held virtually from June 4-8.
A combination of two drugs that target different proteins on immune system T cells kept advanced melanoma in check significantly longer than one of the drugs alone in a phase 3 clinical trial involving 714 patients. Dana-Farber Cancer Institute investigators co-led the study.
Dana-Farber Cancer Institute researchers are presenting dozens of research studies at the 2021 Annual Meeting of the American Society of Clinical Oncology (ASCO). The studies will be presented during the virtual program on June 4-8, 2021. ASCO is the world’s largest clinical cancer research meeting, attracting more than 30,000 oncology professionals from around the world.
Seniors who are enrolled in both Medicare and Medicaid are at risk for experiencing greater worsening of functional status following ICU hospitalization, according to research presented at the ATS 2021 International Conference.
Results from the NAVIGATOR study of tezepelumab showed that the new biologic therapy significantly reduced exacerbations requiring hospital stays and emergency department (ED) visits for adults and adolescents with severe, uncontrolled asthma, according to research presented at the ATS 2021 International Conference. NAVIGATOR (NCT03347279) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial.
Results from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages 6-11 with uncontrolled moderate-to-severe asthma, compared to placebo, according to research presented at the ATS 2021 International Conference. VOYAGE (NCT02948959) is a recently completed randomized, placebo-controlled double-blind multicenter phase 3 clinical trial, that took place in a number of countries.
Dr. Anne Rimoin, UCLA Fielding School of Public Health professor of epidemiology, will present a keynote address at this month’s LABest 2021 conference, a yearly life sciences conference hosted by the university. Rimoin will present the conference’s final keynote - “COVID-19 and Beyond: Preventing the Next Pandemic Before it Starts” at the beginning of the event’s third day, Thursday, May 27, from 11 a.m. to 11:30 a.m.
Approximately two-fifths of Medicare beneficiaries with chronic obstructive pulmonary disease (COPD) have limited access to pulmonary rehabilitation services due to their distance from rehab centers, according to research presented at the ATS 2021 International Conference. More than 24 million U.S. adults suffer from COPD, a smoking related disease.
Environmental tobacco smoke exposure in utero and during early childhood—especially secondhand smoke—is associated with decreased childhood lung function, according to research presented at the ATS 2021 International Conference.
The more severe a patient’s obstructive sleep apnea (OSA), the greater their risk of contracting COVID-19, according to research presented at the ATS 2021 International Conference. The study also found that the longer patients used positive airway pressure (PAP) each night, the more they lowered their COVID-19 risk.
Some patients with coronary artery disease and non-sleepy obstructive sleep apnea (OSA) may be protected against serious cardiac events by CPAP therapy, according to research presented at the ATS 2021 International Conference.
Air quality standards recommended by the American Thoracic Society (ATS) have the potential to prevent more illness and death than standards adopted by the U.S. Environmental Protection Agency (EPA), according to research presented at the ATS 2021 International Conference.
The COVID-19 pandemic has, and will continue to have, a tremendous impact on ICU nurses’ mental health and willingness to continue in the critical care work force, according to research presented at the ATS 2021 International Conference.
New research from the Intermountain Healthcare Heart Institute in Salt Lake City finds that higher EPA blood levels alone lowered the risk of major cardiac events and death in patients, while DHA blunted the cardiovascular benefits of EPA. Higher DHA levels at any level of EPA worsened health outcomes, study finds.
Patients with idiopathic pulmonary fibrosis (IPF), a rare lung disease that causes shortness of breath and low oxygen levels because of lung scarring, have worse outcomes if they live in poor neighborhoods, according to research presented at the ATS 2021 International Conference.